Lumexa Imaging (NASDAQ:LMRI) Shares Gap Up After Analyst Upgrade

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI)’s share price gapped up prior to trading on Friday after KeyCorp upgraded the stock to a strong-buy rating. The stock had previously closed at $9.88, but opened at $10.25. Lumexa Imaging shares last traded at $10.0710, with a volume of 11,733 shares changing hands.

LMRI has been the topic of a number of other research reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Lumexa Imaging in a report on Tuesday. Deutsche Bank Aktiengesellschaft set a $16.00 price target on Lumexa Imaging in a research report on Thursday, August 13th. Barclays upped their target price on Lumexa Imaging from $9.00 to $13.00 and gave the company an “overweight” rating in a report on Friday, August 28th. Finally, Wall Street Zen lowered shares of Lumexa Imaging from a “buy” rating to a “hold” rating in a report on Saturday, September 12th. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, Lumexa Imaging currently has a consensus rating of “Buy” and a consensus price target of $17.50.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in LMRI. Strs Ohio bought a new position in shares of Lumexa Imaging in the 1st quarter worth $38,000. PNC Financial Services Group Inc. bought a new position in Lumexa Imaging in the 1st quarter valued at about $63,000. State of Wyoming bought a new position in Lumexa Imaging in the 1st quarter valued at about $91,000. AXQ Capital LP acquired a new position in Lumexa Imaging during the 2nd quarter valued at about $128,000. Finally, Bank of America Corp DE bought a new stake in Lumexa Imaging during the 2nd quarter worth approximately $200,000.

Lumexa Imaging Trading Up 0.7%

The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 1.40. The firm has a 50 day moving average price of $11.39 and a 200 day moving average price of $10.42. The stock has a market capitalization of $955.61 million and a PE ratio of -20.30.

Lumexa Imaging (NASDAQ:LMRI) last announced its quarterly earnings results on Wednesday, August 12th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.17. The company had revenue of $264.16 million for the quarter. Lumexa Imaging has set its FY 2026 guidance at 0.710-0.770 EPS. Equities analysts expect that Lumexa Imaging Holdings, Inc. will post 0.25 EPS for the current fiscal year.

About Lumexa Imaging

Lumexa Imaging, Inc (NASDAQ: LMRI) is an outpatient diagnostic imaging company that provides medical imaging services to patients and referring healthcare providers in the United States. Its services are designed to support the diagnosis, monitoring and management of a wide range of medical conditions.

The company’s imaging capabilities include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET/CT), ultrasound, mammography and X-ray services. Lumexa also provides related radiology and imaging-support services through its outpatient centers and other care-delivery arrangements.

Lumexa Imaging was formerly known as Akumin Inc and adopted the Lumexa Imaging name as part of its corporate rebranding.